Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07126886 · ClinicalTrials.gov registry record · Phase 4

A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers

A Phase 4 study of Pressure Ulcer and Ulcer, Pressure, sponsored by Applied Biologics.

Recruiting
Registry status
Phase 4
Development phase
100
Enrollment target
1
Study location

NCT07126886 is a Phase 4 study of Pressure Ulcer and Ulcer, Pressure that is actively recruiting participants, run by Applied Biologics. The registered enrollment target is 100 participants, below the 30,107-participant average among 10 other Pressure Ulcer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07126886, a Phase 4 study of Pressure Ulcer and Ulcer, Pressure, is actively recruiting participants, sponsored by Applied Biologics.

RECRUITING
Registry status
Phase 4
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

A multicenter, prospective, clinical trial evaluating a single-layer amniotic membrane (XPURT) and standard of care versus matched controls in the management of nonhealing pressure ulcers.

Interventions

  • OTHER Standard of Care
  • OTHER XPURT + SOC

Study Locations (1)

Pennsylvania

  • Serena Group- Monroeville - Monroeville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-06-11
Est. Completion 2027-08
Phase Phase 4

Sponsor

Applied Biologics

4 total trials

What the Registry Record Tells You About NCT07126886

The ClinicalTrials.gov registry entry for NCT07126886 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 30,107-participant average among 10 other Pressure Ulcer trials with a reported enrollment target (100% lower). The listed sponsor is Applied Biologics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Pressure Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT07126886 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT07126886 about?

NCT07126886 is a clinical study titled "A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers". A multicenter, prospective, clinical trial evaluating a single-layer amniotic membrane (XPURT) and standard of care versus matched controls in the management of nonhealing pressure ulcers.

What is the current status of trial NCT07126886?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2025-06-11. Estimated completion is 2027-08.

What conditions does trial NCT07126886 study?

This clinical trial studies the following conditions: Pressure Ulcer, Ulcer, Pressure, Pressure Wound, Pressure Area.

What interventions are being tested in trial NCT07126886?

The interventions under investigation include: Standard of Care (OTHER), XPURT + SOC (OTHER).

Who is sponsoring clinical trial NCT07126886?

This trial is sponsored by Applied Biologics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07126886 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pressure Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.